Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we’re joined by experts from Belgium, Luxembourg and the Netherlands, three nations that sit in the heart of the EU and take a collaborative approach to pharmaceuticals and healthcare.
We explore what challenges they are facing when new and innovative medicines are on the way to being authorised, what solutions are being pursued to ensure these treatments reach patients, and what this could mean for other countries in Europe.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460080
Hosted on Acast. See acast.com/privacy for more information.